Lead sponsor
Janssen Korea, Ltd., Korea
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
2,083
Total enrollment
0
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
2
Not applicable
1
Trials by status
Completed
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Study to Show That the Change of Attention Measure is Correlated With the Changes of Caregiver's Burden After Treatment With Galantamine in Patients With Alzheimer's DiseaseAlzheimer's diseaseN/ACompleted1,882
The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeAlzheimer's diseasePh 4Completed102
The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's DiseaseAlzheimer's diseasePh 4Completed99